New Vaccine Introduction
In support of USAID’s efforts to help vaccinate 300 million children by 2020, we provide focused technical assistance to prepare countries for the smooth and successful introduction of new, lifesaving vaccines. This technical assistance builds on the work of MCSP’s predecessor program – the Maternal and Child Health Integrated Program – applying lessons learned from assisting in 24 introductions of new vaccines* in 13 Gavi-eligible countries.
The Program strengthens country capacity to introduce new vaccines that have the potential to dramatically reduce the burden of disease and protect children against vaccine preventable diseases. We work in close partnership with Ministries of Health to:
- Provide technical input into Gavi applications;
- Update comprehensive multi-year plans;
- Develop vaccine introduction strategy;
- Plot all program aspects of introduction;
- Assist with launches;
- Monitor the introduction process; and
- Participate in post-introduction evaluations.
Some of these critical areas receive relatively limited attention from partners. MCSP focuses on addressing the detailed operational steps required for high-quality services and equitable coverage in both the immediate and long term, utilizing a comprehensive approach to the steps required for successful vaccine introduction. We use new vaccine introduction as an opportunity to systematically identify and address chronic problems underlying poor routine immunization program performance.
MCSP also plays a key role in global technical leadership, influencing global and regional policies and strategies through engagement in technical advisory groups and other mechanisms. Our engagement and input are infused with practical country-level program implementation experience.
* pneumococcal conjugate, rotavirus, measles second dose and measles rubella, meningococcal A, pentavalent, and inactivated polio vaccines